96.79
Healthequity Inc stock is traded at $96.79, with a volume of 893.76K.
It is down -0.62% in the last 24 hours and down -3.69% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$97.39
Open:
$97.9
24h Volume:
893.76K
Relative Volume:
1.02
Market Cap:
$8.27B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
88.80
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
+2.41%
1M Performance:
-3.69%
6M Performance:
-6.92%
1Y Performance:
+1.88%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
96.79 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
VEEV
Veeva Systems Inc
|
223.26 | 37.72B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.61 | 13.14B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.85 | 8.31B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
36.54 | 6.47B | 11.99B | 24.18M | 234.31M | 0.2956 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
What analysts say about HealthEquity Inc stockLarge Cap Stability Picks & Plan Every Trade With Controlled Risk - earlytimes.in
Bayesian Capital Management LP Acquires New Holdings in HealthEquity, Inc. $HQY - MarketBeat
HSI Hosts 5th Annual Race & Health Equity Awards for Habilitative Systems - The Chicago Crusader
HealthEquity (HQY): Revisiting Valuation After a Flat Month and Ongoing Earnings Growth - Sahm
HealthEquity (NASDAQ:HQY) Upgraded to "Strong-Buy" at Barclays - MarketBeat
HealthEquity (NASDAQ:HQY) Nasdaq Index Fund Scalable Health Solutions - Kalkine Media
HealthEquity (HQY) Moves to Buy: Rationale Behind the Upgrade - sharewise.com
Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes" - sharewise.com
Next Century Growth Investors LLC Grows Stock Holdings in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. $HQY Shares Acquired by Baird Financial Group Inc. - MarketBeat
HealthEquity (HQY) Is Down 5.5% After Raising 2025 Guidance And Stepping Up Buybacks – Has The Bull Case Changed? - simplywall.st
Barclays Initiates Coverage of HealthEquity (HQY) with Overweight Recommendation - Nasdaq
Why (HQY) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Barclays Initiates Coverage on HQY with Overweight Rating and $1 - GuruFocus
HealthEquity's Inaugural Healthcare Affordability Pulse Survey Reveals Economic Anxiety Among Younger Americans Despite Increased HSA Adoption - Quiver Quantitative
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds - Yahoo Finance
HealthEquity initiated with an Overweight at Barclays - TipRanks
Declining Stock and Decent Financials: Is The Market Wrong About HealthEquity, Inc. (NASDAQ:HQY)? - 富途牛牛
HealthEquity (HQY): Revisiting Valuation After Recent Pullback and Strong Three-Year Shareholder Returns - Yahoo Finance
Steward Partners Investment Advisory LLC Has $90,000 Holdings in HealthEquity, Inc. $HQY - MarketBeat
Volume Recap: How strong dollar benefits HealthEquity Inc 2HE stockBull Run & Daily Chart Pattern Signal Reports - moha.gov.vn
Invesco Ltd. Sells 80,338 Shares of HealthEquity, Inc. $HQY - MarketBeat
Is HealthEquity Stock Built to Withstand More Downside? - Trefis
HealthEquity Inc. Reports Strong Q3 Earnings and Growth - TipRanks
HealthEquity (NASDAQ:HQY) Receives Outperform Rating from Barrington Research - MarketBeat
HealthEquity (NASDAQ:HQY) Price Target Raised to $129.00 at JPMorgan Chase & Co. - MarketBeat
Deutsche Bank Adjusts Price Target on HealthEquity to $120 From $117, Maintains Buy Rating - marketscreener.com
HealthEquity, Inc. (NASDAQ:HQY) Q3 2026 earnings call transcript - MSN
HealthEquity (NASDAQ:HQY) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
HealthEquity (NASDAQ:HQY) Receives Buy Rating from BTIG Research - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Q3 2026 Earnings Call Transcript - Insider Monkey
Norges Bank Makes New Investment in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity (HQY): Analyst Maintains Rating and Raises Price Ta - GuruFocus
Can HealthEquity Inc. (2HE) stock sustain revenue momentumWeekly Investment Recap & Step-by-Step Swing Trade Plans - Newser
EverSource Wealth Advisors LLC Raises Stock Position in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. $HQY Shares Sold by Brown Advisory Inc. - MarketBeat
Will HealthEquity Inc. (2HE) stock draw ESG focused fundsQuarterly Portfolio Report & Accurate Buy Signal Alerts - Newser
How HealthEquity Inc. (2HE) stock compares with tech leadersJuly 2025 Retail & Smart Allocation Stock Tips - Newser
How currency fluctuations impact HealthEquity Inc. stockMarket Rally & Reliable Breakout Forecasts - Newser
HealthEquity Inc (HQY) Q3 2026 Earnings Call Highlights: Robust Growth and Strategic ... By GuruFocus - Investing.com Canada
HealthEquity (NASDAQ:HQY) Updates FY 2026 Earnings Guidance - MarketBeat
HealthEquity (NASDAQ:HQY) Announces Quarterly Earnings Results - MarketBeat
Citizens Maintains HealthEquity (HQY) Market Outperform Recommendation - Nasdaq
Is HealthEquity Inc. (2HE) stock vulnerable to rate hikesMarket Activity Recap & Target Return Focused Stock Picks - Newser
BofA Securities reiterates Buy rating on HealthEquity stock, citing margin expansion By Investing.com - Investing.com South Africa
HealthEquity price target raised to $129 from $126 at JPMorgan - TipRanks
HealthEquity (HQY) Rating Maintained as 'Outperform' by Barringt - GuruFocus
HealthEquity (HQY) Analyst Rating Update: JP Morgan Raises Price Target | HQY Stock News - GuruFocus
Healthequity Inc (NASDAQ:HQY) Topline Grows 7% - FXDailyReport.Com
HealthEquity Stock Gains as Q3 Earnings Beat Estimates, Revenues Up Y/Y - Yahoo Finance
BofA Securities reiterates Buy rating on HealthEquity stock, citing margin expansion - Investing.com Australia
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Healthequity Inc Stock (HQY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ladd Delano | EVP, General Counsel |
Nov 20 '25 |
Sale |
104.56 |
1,500 |
156,840 |
75,479 |
| Ladd Delano | EVP, General Counsel |
Oct 20 '25 |
Sale |
92.07 |
1,500 |
138,105 |
76,979 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):